Millennium reports 7.32M shares (4.96%) of Maravai

Rhea-AI Filing Summary

Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander filed a Schedule 13G reporting shared beneficial ownership of 7,323,520 shares (4.96%) of Maravai LifeSciences Holdings, Inc. Class A common stock (CUSIP 56600D107) with a June 16, 2026 ownership date.

The filing states the reported shares reflect shared voting and shared dispositive power of 7,323,520 and notes that, after acquiring beneficial ownership of more than 5% on June 16, 2026, the reporting persons ceased to be beneficial owners of more than 5% by the date of this filing. The filing is accompanied by a Joint Filing Agreement dated June 22, 2026.

Insights

Institutional Ownership Analyst

Large asset manager reports a passive 4.96% shared stake as of June 16, 2026.

The filing lists 7,323,520 shares held with shared voting and dispositive power by entities managed or controlled by Millennium Management LLC and associates. The statement clarifies group ownership structure and includes a Joint Filing Agreement dated June 22, 2026.

Because the filing reports a 4.96% position and indicates the reporting persons ceased to hold more than 5% by the filing date, this is a routine institutional disclosure of holdings; cash‑flow treatment and trade methods are not provided in the excerpt.

Key Figures

Filing type: Schedule 13G Shared voting/dispositive power: 7,323,520 shares Percent of class: 4.96% +3 more

6 metrics

Filing type Schedule 13G Ownership disclosure for Class A common stock

Shared voting/dispositive power 7,323,520 shares Reported on cover rows as shared voting and shared dispositive power

Percent of class 4.96% Percent shown on cover rows, ownership as of <date>June 16, 2026</date>

Ownership date June 16, 2026 Date after which reporting persons ceased to be >5% by filing date

Joint Filing Agreement dated June 22, 2026 Exhibit I to the Schedule 13G

CUSIP 56600D107 Class A Common Stock identifier shown on cover page

Key Terms

Schedule 13G, Shared dispositive power, Joint Filing Agreement

3 terms

Schedule 13G regulatory

"Item 1. | (a) | Name of issuer: Maravai LifeSciences Holdings, Inc."

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

Shared dispositive power financial

"6 | Shared Voting Power 7,323,520.00 ... 8 | Shared Dispositive Power 7,323,520.00"

Joint Filing Agreement regulatory

"Exhibit I: Joint Filing Agreement, dated as of June 22, 2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Millennium Management report in Maravai (MRVI)?

They report shared beneficial ownership of 7,323,520 shares, representing 4.96% of Class A common stock as of June 16, 2026. The filing attributes shared voting and dispositive power to the reporting entities.

Did the filing say Millennium still holds more than 5% of MRVI?

No. The filing states the reporting persons acquired beneficial ownership of more than 5% on June 16, 2026 but ceased to be beneficial owners of more than 5% by the filing date, per Item 4 language.

Which entities signed the Schedule 13G for MRVI?

The Schedule 13G was filed by Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander, and it includes a Joint Filing Agreement dated June 22, 2026 among those parties.

What voting or dispositive power is reported over the shares?

The cover-page entries show shared voting power of 7,323,520 shares and shared dispositive power of 7,323,520 shares, with no sole voting or sole dispositive power reported on the cover rows.

Where is Maravai's principal executive office listed in the filing?

The filing lists Maravai LifeSciences Holdings' principal executive offices at 10770 Wateridge Circle, Suite 200, San Diego, California 92121 in Item 1(b) of the Schedule 13G.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/23/2026 - 06:52 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Maravai LifeSciences Holdings, Inc.

(Name of Issuer)

Class A Common Stock, par value $0.01 per share

(Title of Class of Securities)

56600D107

(CUSIP Number)

06/16/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 56600D107

1

Names of Reporting Persons

Millennium Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 7,323,520.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,323,520.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,323,520.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.96 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 56600D107

1

Names of Reporting Persons

Millennium Group Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 7,323,520.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,323,520.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,323,520.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.96 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 56600D107

1

Names of Reporting Persons

Israel A. Englander

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 7,323,520.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,323,520.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,323,520.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.96 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Maravai LifeSciences Holdings, Inc.
(b)	Address of issuer's principal executive offices: 10770 Wateridge Circle, Suite 200, San Diego, California 92121
Item 2.
(a)	Name of person filing: Millennium Management LLC Millennium Group Management LLC Israel A. Englander
(b)	Address or principal business office or, if none, residence: Millennium Management LLC 399 Park Avenue New York, New York 10022 Millennium Group Management LLC 399 Park Avenue New York, New York 10022 Israel A. Englander c/o Millennium Management LLC 399 Park Avenue New York, New York 10022
(c)	Citizenship: Millennium Management LLC - Delaware Millennium Group Management LLC - Delaware Israel A. Englander - United States
(d)	Title of class of securities: Class A Common Stock, par value $0.01 per share
(e)	CUSIP Number(s): 56600D107
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See response to Item 9 on each cover page. After acquiring beneficial ownership of more than 5% of the outstanding Class A Common Stock on June 16, 2026, the reporting persons ceased to be beneficial owners of more than 5% of the outstanding Class A Common Stock by the date of this filing.
(b)	Percent of class: See response to Item 11 on each cover page.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See response to Item 5 on each cover page.
	(ii) Shared power to vote or to direct the vote: See response to Item 6 on each cover page.
	(iii) Sole power to dispose or to direct the disposition of: See response to Item 7 on each cover page.
	(iv) Shared power to dispose or to direct the disposition of: See response to Item 8 on each cover page. The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(K), so indicate under Item 3(k) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group. See Exhibit I
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Millennium Management LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	06/22/2026

Millennium Group Management LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	06/22/2026

Israel A. Englander

Signature:	/s/ Israel A. Englander
Name/Title:	Israel A. Englander
Date:	06/22/2026

Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of June 22, 2026, by and among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.